Total Payments
$96,719
2024 Payments
$1,165
Companies
30
Transactions
913
Medicare Patients
1,227
Medicare Billing
$281,879
Payment Breakdown by Category
Other$68,975 (71.3%)
Food & Beverage$17,654 (18.3%)
Consulting$6,698 (6.9%)
Travel$3,240 (3.3%)
Education$152.67 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $68,975 | 52 | 71.3% |
| Food and Beverage | $17,654 | 832 | 18.3% |
| Consulting Fee | $6,698 | 4 | 6.9% |
| Travel and Lodging | $3,240 | 16 | 3.3% |
| Education | $152.67 | 9 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $67,267 | 260 | $0 (2024) |
| GlaxoSmithKline, LLC. | $15,601 | 59 | $0 (2024) |
| UCB, Inc. | $2,228 | 46 | $0 (2024) |
| Amgen Inc. | $1,954 | 97 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,708 | 93 | $0 (2024) |
| Celgene Corporation | $1,565 | 11 | $0 (2019) |
| Janssen Biotech, Inc. | $1,307 | 66 | $0 (2024) |
| PFIZER INC. | $1,291 | 75 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $833.57 | 39 | $0 (2023) |
| GENZYME CORPORATION | $579.53 | 34 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,165 | 49 | Amgen Inc. ($243.57) |
| 2023 | $6,203 | 82 | AbbVie Inc. ($4,950) |
| 2022 | $25,245 | 153 | ABBVIE INC. ($22,499) |
| 2021 | $5,043 | 95 | AbbVie Inc. ($3,658) |
| 2020 | $16,586 | 93 | GlaxoSmithKline, LLC. ($10,034) |
| 2019 | $22,567 | 201 | AbbVie, Inc. ($14,050) |
| 2018 | $8,544 | 116 | AbbVie, Inc. ($6,944) |
| 2017 | $11,366 | 124 | AbbVie, Inc. ($9,732) |
All Payment Transactions
913 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Bone Health | ||||||
| 11/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $23.59 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: VACCINE | ||||||
| 11/07/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $35.33 | General |
| Category: Rheumatology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 10/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Endocrinology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Lilly USA, LLC | TALTZ (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Immunology | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $30.08 | General |
| Category: Immunology | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: Immunology | ||||||
| 09/18/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Rheumatology | ||||||
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 09/09/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: Not Applicable | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $33.12 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/19/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: Inflammation | ||||||
| 08/19/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Immunology | ||||||
| 08/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: IMMUNOLOGY | ||||||
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $18.57 | General |
| Category: Immunology | ||||||
| 08/06/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 291 | 737 | $168,116 | $65,681 |
| 2022 | 4 | 318 | 859 | $198,104 | $77,717 |
| 2021 | 4 | 305 | 806 | $187,282 | $75,314 |
| 2020 | 5 | 313 | 815 | $190,551 | $63,168 |
Total Patients
1,227
Total Services
3,217
Medicare Billing
$281,879
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 619 | $143,608 | $56,648 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 60 | $9,360 | $3,732 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $9,308 | $3,356 | 36.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 23 | 32 | $5,840 | $1,945 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 224 | 721 | $167,272 | $65,557 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 44 | 44 | $15,752 | $5,793 | 36.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 62 | $9,672 | $4,153 | 42.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 21 | 32 | $5,408 | $2,213 | 40.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 222 | 688 | $159,616 | $64,978 | 40.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 43 | 43 | $15,394 | $5,448 | 35.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 22 | 44 | $7,436 | $2,755 | 37.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 31 | $4,836 | $2,132 | 44.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 207 | 679 | $157,528 | $51,368 | 32.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 43 | 44 | $15,752 | $5,718 | 36.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 45 | $7,020 | $2,548 | 36.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 16 | 30 | $4,964 | $1,786 | 36.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 17 | $5,287 | $1,748 | 33.1% |
About Dr. Beth Valashinas, DO
Dr. Beth Valashinas, DO is a Internal Medicine healthcare provider based in Orange, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1114184306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Valashinas, DO has received a total of $96,719 in payments from pharmaceutical and medical device companies, with $1,165 received in 2024. These payments were reported across 913 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($68,975).
As a Medicare-enrolled provider, Valashinas has provided services to 1,227 Medicare beneficiaries, totaling 3,217 services with total Medicare billing of $281,879. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology, Rheumatology
- Location Orange, CT
- Active Since 05/16/2008
- Last Updated 06/19/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1114184306
Products in Payments
- RINVOQ (Biological) $25,044
- Humira (Biological) $13,000
- BENLYSTA (Biological) $11,921
- SKYRIZI (Biological) $5,961
- HUMIRA (Biological) $5,130
- ORENCIA (Biological) $1,708
- Enbrel (Biological) $1,643
- Otezla (Drug) $1,611
- XELJANZ (Drug) $1,265
- Cimzia (Drug) $907.75
- COSENTYX (Biological) $806.06
- TREMFYA (Drug) $706.56
- RAYOS (Drug) $396.06
- KEVZARA (Drug) $338.26
- Rituxan (Biological) $332.31
- STELARA (Biological) $310.66
- TALTZ (Drug) $302.13
- RINVOQ (Drug) $245.61
- KEVZARA (Biological) $217.75
- KRYSTEXXA (Biological) $206.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Orange
Dr. May Cho, M.d, M.D
Internal Medicine — Payments: $335,831
Internal Medicine $335,831
Dr. Elizabeth Brem, Md, MD
Internal Medicine — Payments: $285,872
Internal Medicine $285,872
Dr. Ritesh Parajuli, Md, MD
Internal Medicine — Payments: $180,846
Internal Medicine $180,846
Dr. Jennifer Valerin, M.d, M.D
Internal Medicine — Payments: $83,603
Internal Medicine $83,603
Dr. Teferi Mitiku, M.d, M.D
Internal Medicine — Payments: $69,169
Internal Medicine $69,169
Sendhil Krishnan, Md, Facc, MD, FACC
Internal Medicine — Payments: $40,364
Internal Medicine $40,364